Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
What information is available on drugs in diving?

Original article by: Emma Templeman, Emma Shepherd and Julia Kuczynska, South West Medicines Information and Training, Bristol

Publisher: South West Medicines Information and Training

Keywords: Diving;

Date published: 22/11/2011 15:13

Review date: 30/11/2013 10:27

Summary
by: Julia Kuczynska
  • There are several sources of information on drugs and medical conditions that may affect a person’s ability to dive.
  • Professional divers are required by law to undergo a medical assessment by a clinician trained in diving medicine and approved by the Health and Safety Executive (HSE). 
  • Recreational divers undergoing training run by organisations such as the Sub Aqua Club are also required to disclose certain medical conditions and undergo a medical examination if necessary.
  • Medical fitness to dive using medication depends upon the type of diving, underlying pathology, effects of medication on fitness to dive and the consequences of its abrupt cessation during diving activities.
  • The underlying condition for which medication is being taken may be the most important consideration.
  • Certain drugs e.g. sedatives, anticoagulants, antidepressants, are not compatible with diving or restrict the type of diving the person can do
  • Consideration should be given to the potential for unexpected side effects as a result of interaction with increased partial pressures of nitrogen. This may increase the drowsiness caused by many drugs such as antihistamines and medications for motion sickness.
Link

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Related evidence
2.8.2 Oral anticoagulants
14/02/2012
SMC accepts the use of rivaroxaban (Xarelto™) for the treatment of DVT and the prevention of recurrent DVT and PE following an acute DVT in adults
27/01/2012
A briefing paper on dabigatran and rivaroxaban
25/01/2012
NICE issues final guidance on apixaban for the prevention of VTE after total hip or knee replacement in adults
4.1.1 Hypnotics
18/11/2011
Melatonin for non-respiratory sleep disorders in visually impaired children
28/05/2010
Sodium oxybate (Xyrem®) in the management of narcolepsy with cataplexy
26/03/2010
Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
4.1.2 Anxiolytics
08/02/2011
New CKS Topic: Delirium
12/10/2010
CKS Topic: Temporomandibular joint disorders
15/06/2007
Psychotropic analgesic nitrous oxide for alcoholic withdrawal states
4.3 Antidepressant drugs
31/12/2011
Mirtazapine versus other antidepressive agents for depression
04/04/2011
NICE issues depression quality standard
16/02/2011
Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis
4.6 Drugs used in nausea and vertigo
08/11/2011
SMC does not recommend aprepitant (Emend®) for the prevention of chemotherapy-induced nausea and vomiting
07/03/2011
SMC accepts fosaprepitant dimeglumine (IVEmend®) for prevention of nausea and vomiting associated with highly emetogenic cisplatin-based chemotherapy
08/02/2011
New CKS Topic: benign paroxysmal positional vertigo
4.8 Antiepileptic drugs
14/02/2012
SMC accepts midazolam oromucosal solution (Buccolam™) for treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents
05/02/2012
Vigabatrin versus carbamazepine monotherapy for epilepsy
26/01/2012
NICE issues guidelines on diagnosis and management of the epilepsies in adults and children in primary and secondary care
5.4.1 Antimalarials
04/05/2011
DTB update: Artemisinins in malaria treatment in the UK
08/11/2010
Drug and Therapeutics Bulletin: artemisinins for malaria in the UK
23/03/2010
CKS topic review: Malaria
Sports medicine
13/11/2008
Systematic review: the effects of growth hormone on athletic performance
24/07/2008
CKS Topic Review: sprains and strains
11/01/2006
Hyperbaric oxygen therapy for delayed onset muscle soreness and closed soft tissue injury
Travel medicine
22/09/2009
CKS Topic Minibite: Traveller’s diarrhoea
29/01/2009
A systematic review and meta-analysis of the effectiveness and safety of atovaquone-proguanil (Malarone) for chemoprophylaxis against malaria
14/12/2006
Melatonin for treatment of sleep disorders
Back